Stimulation of the Production of Hypericins in in Vitro Seedlings of Hypericum Adenotrichum by Some Biotic Elicitors
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
St. John's Wort 2018
ONLINE SERIES MONOGRAPHS The Scientific Foundation for Herbal Medicinal Products Hyperici herba St. John's Wort 2018 www.escop.com The Scientific Foundation for Herbal Medicinal Products HYPERICI HERBA St. John's Wort 2018 ESCOP Monographs were first published in loose-leaf form progressively from 1996 to 1999 as Fascicules 1-6, each of 10 monographs © ESCOP 1996, 1997, 1999 Second Edition, completely revised and expanded © ESCOP 2003 Second Edition, Supplement 2009 © ESCOP 2009 ONLINE SERIES ISBN 978-1-901964-61-5 Hyperici herba - St. John's Wort © ESCOP 2018 Published by the European Scientific Cooperative on Phytotherapy (ESCOP) Notaries House, Chapel Street, Exeter EX1 1EZ, United Kingdom www.escop.com All rights reserved Except for the purposes of private study, research, criticism or review no part of this text may be reproduced, stored in a retrieval system or transmitted, in any form or by any means, without the written permission of the publisher. Important Note: Medical knowledge is ever-changing. As new research and clinical experience broaden our knowledge, changes in treatment may be required. In their efforts to provide information on the efficacy and safety of herbal drugs and herbal preparations, presented as a substantial overview together with summaries of relevant data, the authors of the material herein have consulted comprehensive sources believed to be reliable. However, in view of the possibility of human error by the authors or publisher of the work herein, or changes in medical knowledge, neither the authors nor the publisher, nor any other party involved in the preparation of this work, warrants that the information contained herein is in every respect accurate or complete, and they are not responsible for any errors or omissions or for results obtained by the use of such information. -
Assessment Report on Hypericum Perforatum L., Herba
European Medicines Agency Evaluation of Medicines for Human Use London, 12 November 2009 Doc. Ref.: EMA/HMPC/101303/2008 COMMITTEE ON HERBAL MEDICINAL PRODUCTS (HMPC) ASSESSMENT REPORT ON HYPERICUM PERFORATUM L., HERBA 7 Westferry Circus, Canary Wharf, London, E14 4HB, UK Tel. (44-20) 74 18 84 00 Fax (44-20) 75 23 70 51 E-mail: [email protected] http://www.emea.europa.eu © European Medicines Agency, 2009. Reproduction is authorised provided the source is acknowledged TABLE OF CONTENTS I. REGULATORY STATUS OVERVIEW...................................................................................4 II. ASSESSMENT REPORT............................................................................................................5 II.1 INTRODUCTION..........................................................................................................................6 II.1.1 Description of the herbal substance(s), herbal preparation(s) or combinations thereof 6 II.1.1.1 Herbal substance:........................................................................................................ 6 II.1.1.2 Herbal preparation(s): ................................................................................................ 7 II.1.1.3 Combinations of herbal substance(s) and/or herbal preparation(s)........................... 9 Not applicable. ................................................................................................................................9 II.1.1.4 Vitamin(s) ................................................................................................................... -
-
Toxicity Assessment of Hypericum Olympicum Subsp. Olympicum L. On
J Appl Biomed journal homepage: http://jab.zsf.jcu.cz DOI: 10.32725/jab.2020.002 Journal of Applied Biomedicine Original research article Toxicity assessment of Hypericum olympicum subsp. olympicum L. on human lymphocytes and breast cancer cell lines Necmiye Balikci 1, Mehmet Sarimahmut 1, Ferda Ari 1, Nazlihan Aztopal 1, 2, Mustafa Zafer Özel 3, Engin Ulukaya 1, 4, Serap Celikler 1 * 1 Uludag University, Faculty of Science and Arts, Department of Biology, Bursa, Turkey 2 Istinye University, Faculty of Science and Literature, Department of Molecular Biology and Genetics, Istanbul, Turkey 3 University of York, Department of Chemistry, Heslington, York, United Kingdom 4 Istinye University, Faculty of Medicine, Department of Medical Biochemistry, Istanbul, Turkey Abstract There is a limited number of studies about the constituents ofHypericum olympicum subsp. olympicum and its genotoxic and cytotoxic potency. We examined the possible antigenotoxic/genotoxic properties of methanolic extract of H. olympicum subsp. olympicum (HOE) on human lymphocytes by employing sister chromatid exchange, micronucleus and comet assay and analyzed its chemical composition by GCxGC-TOF/MS. The anti-growth activity against MCF-7 and MDA-MB-231 cell lines was assessed by using the ATP viability assay. Cell death mode was investigated with fluorescence staining and ELISA assays. The major components of the flower and trunk were determined as eicosane, heptacosane, 2-propen-1-ol, hexahydrofarnesyl acetone and α-muurolene. HOE caused significant DNA damage at selected doses (250–750 µg/ml) while chromosomal damage was observed at higher concentrations (500 and 750 µg/ml). HOE demonstrated anti-growth activity in a dose-dependent manner between 3.13–100 µg/ml. -
Natural Products of Relevance in the Prevention and Supportive Treatment of Depression
Psychiatr. Pol. 2015; 49(3): 435–453 PL ISSN 0033-2674 (PRINT), ISSN 2391-5854 (ONLINE) www.psychiatriapolska.pl DOI: http://dx.doi.org/10.12740/PP/29367 Natural products of relevance in the prevention and supportive treatment of depression Bożena Muszyńska1, Maciej Łojewski 1,Jacek Rojowski 2, Włodzimierz Opoka 2, Katarzyna Sułkowska-Ziaja1 1Chair and Department of Pharmaceutical Botany, Jagiellonian University Medical College Head: prof. dr hab. H. Ekiert 2Chair of Inorganic and Analytical Chemistry, Faculty of Pharmacy, Jagiellonian University Medical College Head: dr hab. W. Opoka, prof. of Jagiellonian University Summary The use of herbs or their parts: leaves, roots, rhizomes, flowers, seeds, natural strains, as well as extracts or isolated metabolites is becoming more and more popular. Natural remedies not only act prophylactically, but also help to alleviate symptoms of many diseases and enhance the overall functioning of the internal organs. Many raw materials of natural origin plays a role in treatment of health problems, and also in case of serious diseases such as depression. Depres- sion (affective disorder) now affects about 10% of the population, but in next few years due to the development of civilization and increasing pace of life, the probable number of people suffering from this disease can grow rapidly. Natural raw materials such as Bacopa monnieri, Crocus sativus, Eleutherococcus senticosus, Griffonia simplicifolia, Hypericum perforatum, Sceletium tortuosum, Piper methysticum, Rhodiola rosea, Aspalathus linearis, Camellia sinensis, Ficus carica, Lycium chinense, Cuminum cyminum, Panax Ginseng can effectively assist the prevention and treatment of depression. Daily diet may also have positive effect in prevention of this disease. -
LC-MS and LC-PDA Analysis of Hypericum Empetrifolium and Hypericum Sinaicum Feras Q
LC-MS and LC-PDA Analysis of Hypericum empetrifolium and Hypericum sinaicum Feras Q. Alalia,*, Khaled Tawahab, and Mohammad Gharaibehc a Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Al Isra Private University, P. O. Box 22, 33, Amman 11622, Jordan. E-mail: [email protected] b Department of Pharmaceutical Sciences, Faculty of Pharmacy, University of Jordan, Amman 11942, Jordan c Department of Natural Resources and Environment, Faculty of Agriculture, Jordan University of Science and Technology, P. O. Box 3030, Irbid 22110, Jordan * Author for correspondence and reprint requests Z. Naturforsch. 64 c, 476 – 482 (2009); received February 25/March 26, 2009 Within the framework of our continuous efforts to explore Hypericum species from Jor- dan, we report the analysis of the major active metabolites, naphthodianthrones and phloro- glucinols, in the methanolic extracts of two under-explored Hypericum species; H. empetri- folium Willd. and H. sinaicum Hochst. & Steud. ex Boiss., using LC-(+,–)-ESI-MS (TIC and SIM) and LC-UV/Vis spectroscopy. Based on their LC-UV/Vis profi les, retention times and (+,–)-ESI-MS (TIC and SIM) spectral data, hypericin, protohypericin and pseudohypericin were identifi ed in both of the investigated species. In addition adhyperfi rin was only de- tected in H. empetrifolium, while hyperforin and protopseudohypericin were only detected in H. sinaicum. This is the fi rst report documenting the presence of hypericin, protohypericin, pseudohypericin, protopseudohypericin, and hyperforin in H. sinaicum, and adhyperfi rin in H. empetrifolium. Key words: Hypericum, Naphthodianthrones, Phloroglucinols Introduction species of Hypericum can be identifi ed by: (i) op- posite simple entire exstipulate leaves contain- Hypericum is a genus of about 450 species ing translucent and often black or red glandular of herbs or shrubs belonging to the family Clu- secretions; (ii) fl owers with a 5-merous perianth siaceae, formerly Hypericaceae. -
NVEO 2019, Volume 6, Special Issue
NVEO 2019, Volume 6, Special Issue CONTENTS Wellcome address of the Presidents of the Local Organizing Committee......... 2 ISEO 2019 Committees....................................................................................... 3 ISEO Medal of Honour........................................................................................ 4 IFEAT - Young Scientists Fellowship.................................................................... 5 NVEO 2019 Editorial........................................................................................... 6 Scientific Programme......................................................................................... 8 List of Poster Presentations................................................................................ 12 Abstracts............................................................................................................. 18 Sponsors............................................................................................................. 186 50th International Symposium on Essential Oils (ISEO2019) Key of Abbreviations: WS workshop WL welcome lecture PL plenary lecture IS invited speaker OP oral presentation YS young scientist presentation PD panel discussion PP poster presentation YS PP young scientist poster presentation All abstracts are from the 50th International Symposium on Essential Oils (ISEO2019) Abstract Book By Editors: Johannes Novak & Iris Stappen are adapted to the NVEO –ISEO 2019 Special Issue e-ISSN: 2148-9637 Nat. Vol. & Essent. Oils, 2019, 6 -
(12) Patent Application Publication (10) Pub. No.: US 2009/0285919 A1 Alberte Et Al
US 20090285919A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2009/0285919 A1 Alberte et al. (43) Pub. Date: Nov. 19, 2009 (54) RCE BRAN EXTRACTS FOR filed on Sep. 30, 2008, provisional application No. NFLAMMATION AND METHODS OF USE 61/147,305, filed on Jan. 26, 2009. THEREOF Publication Classification (76) Inventors: Randall S. Alberte, Estero, FL (51) Int. Cl. (US); William P. Roschek, JR., A 6LX 36/899 (2006.01) Naples, FL (US) A2.3L I/28 (2006.01) Correspondence Address: A6IP 29/00 (2006.01) FOLEY HOAG, LLP A6IP 25/00 (2006.01) PATENT GROUP, WORLD TRADE CENTER A6IP35/00 (2006.01) WEST (52) U.S. Cl. ......................................... 424/750; 426/655 155 SEAPORT BLVD BOSTON, MA 02110 (US) (57) ABSTRACT The present invention relates in part to stabilized rice bran (21) Appl. No.: 12/467,835 extracts enriched in compounds that have inhibitory activity against certain anti-inflammatory therapeutic endpoints, such (22) Filed: May 18, 2009 as the COX-1, COX-2 and 5-LOX enzymes. Another aspect of the invention relates to pharmaceutical compositions com Related U.S. Application Data prising the extracts and to methods of treating inflammatory (60) Provisional application No. 61/054,151, filed on May diseases comprising administering the aforementioned 18, 2008, provisional application No. 61/101.475, eXtractS. Patent Application Publication Nov. 19, 2009 Sheet 1 of 6 US 2009/0285919 A1 Figure l Arachidonic Acid NSAIDs inhibition Prostaglandins PRO-NFLAMMATORY Arthritis (OA & RA) Patent Application Publication Nov. 19, 2009 Sheet 2 of 6 US 2009/0285919 A1 S.---------------Sssssssssss &s asy xxx s -Yvxxxxxxxxxxxxxxxxxxxx xxxx-xxxxxxxxxx:x O SSSSS i Patent Application Publication Nov. -
Harami Daği (Güvem-Kizilcahamam-Ankara)
HARAMİ DAĞI (GÜVEM-KIZILCAHAMAM-ANKARA) FLORASI THE FLORA OF THE HARAMI MOUNTAIN (GUVEM-KIZILCAHAMAM-ANKARA) SİMGE VARLIK Hacettepe Üniversitesi Lisansüstü Eğitim-Öğretim ve Sınav Yönetmeliğinin Biyoloji Anabilim Dalı için Öngördüğü YÜKSEK LİSANS TEZİ olarak hazırlanmıştır. 2018 HARAMİ DAĞI (GÜVEM-KIZILCAHAMAM-ANKARA) FLORASI THE FLORA OF THE HARAMI MOUNTAIN (GUVEM-KIZILCAHAMAM-ANKARA) SİMGE VARLIK PROF. DR. ŞİNASİ YILDIRIMLI Tez Danışmanı Hacettepe Üniversitesi Lisansüstü Eğitim-Öğretim ve Sınav Yönetmeliğinin Biyoloji Anabilim Dalı için Öngördüğü YÜKSEK LİSANS TEZİ olarak hazırlanmıştır. 2018 ÖZET HARAMİ DAĞI (GÜVEM- KIZILCAHAMAM-ANKARA) FLORASI Simge VARLIK Yüksek Lisans, Biyoloji Bölümü Tez Danışmanı: Prof.Dr. Şinasi YILDIRIMLI Haziran 2018, 98 sayfa Bu çalışma çok az bilinen Kızılcahamam bölgesinde bulunan Harami dağı (Güvem- Kızılcahamam-Ankara) ve çevresinin florasını içermektedir. Harami dağı flora çalışması, Nisan-Haziran 2012, Nisan-Eylül 2016 ve Temmuz 2017 tarihlerini kapsayacak şekilde 34 farklı lokasyondan 581 bitki örneği toplanmasıyla gerçekleştirilmiştir. Elde edilen bulgulara göre 54 familya, 191 cins, 326 tür, 1 yetiştirme tür, 6 alttür, 4 varyete olmak üzere toplam 337 takson tespit edilmiştir. Bu taksonların 1 tanesi Pteridophyta, 336 tanesi Spermatophyta bölümüne aittir. Gymnospermae alt bölümünde 2 takson bulunmaktadır. Angiospermae alt bölümünde 39 takson Monocotyledonae olmak üzere 334 takson bulunmaktadır. Toplam endemik tür sayısı 29 olup endemizm oranı %8.6’dir. Fitocoğrafik bölgelere göre dağılımına bakıldığında, bu taksonların 44’ü (%13.1) Avrupa-Sibirya elementi, 41’i (%12.2) İran-Turan elementi, 25’i (%7.4) Akdeniz ve Doğu Akdeniz elementi ve 227’si (%67.4) çok bölgeli ve bilinmeyendir. En çok taksona sahip familyalar: Asteraceae 48 (%14.3), Fabaceae 46 (%13.7), Lamiaceae 24 (%7.1), Poaceae 20 (%5.6) ve Rosaceae’dir 15 (%4.5). -
An Updated List of Neuromedicinal Plants of Pakistan, Their Uses, and Phytochemistry
Hindawi Evidence-Based Complementary and Alternative Medicine Volume 2019, Article ID 6191505, 27 pages https://doi.org/10.1155/2019/6191505 Review Article An Updated List of Neuromedicinal Plants of Pakistan, Their Uses, and Phytochemistry Abdul Waheed Khan ,1 Arif-ullah Khan ,2 Syed Muhammad Mukarram Shah,3 Aziz Ullah,4 Muhammad Faheem ,2 and Muhammad Saleem2 1 Department of Pharmacy, University of Lahore, Islamabad, Pakistan 2Riphah Institute of Pharmaceutical Sciences, Riphah International University, Islamabad, Pakistan 3Department of Pharmacy, University of Swabi, Khyber Pakhtunkhwa, Pakistan 4Department of Pharmacy, Forman Christian College, Lahore, Pakistan Correspondence should be addressed to Arif-ullah Khan; [email protected] Received 12 November 2018; Revised 14 January 2019; Accepted 5 February 2019; Published 3 March 2019 Guest Editor: Jos´e C. T. Carvalho Copyright © 2019 Abdul Waheed Khan et al. Tis is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Background. Almost every region of Pakistan is stacked with a large number of medicinal plants. Due to high cost and unavailability of allopathic medicines for the neurological diseases, especially in rural areas, traditional healers prescribe phytotherapy for various neurological diseases like epilepsy, depression, anxiety, insomnia, Alzheimer, and migraine. Such treatments are considered to be most efective by the native people. Methods. Te data was collected from articles published on medicinal plants of various districts of Pakistan, using article search engines like Medline, Pubmed, Web of Science, Science Direct, and Google Scholar. Also, information regarding various neurological uses and mode of applications of medicinal plants was obtained from traditional healers, folk medicine users, and local elderly people having knowledge of medicinal plants. -
Antidepressant Activity of Hyperforin Conjugates of the St.John's Wort, Hypericum Perforatum Linn.: an Experimental Study
Indian Journal of Experimental Biology VoL 39, December 2001, pp. 1302-1304 Antidepressant activity of hyperforin conjugates of the St.John's wort, Hypericum perforatum Linn.: An experimental study A V Muruganandam & S K Bhattacharya* Department of Pharmacology, Institute of Medical Sciences, Banaras Hindu University, Varanasi 221 005, India and S Ghosal Drug Research and Deve lopment Centre, 1078, Jessore Road, Calcutta 700 028, India Received 11 November 2000; revised 26 July 2001 Nine extracts of H. petforatwn, containing hyperfo rin in conjugated forms, but devoid of free hyperforin and adhyper forin, were subj ected to antidepressant screening using the forced swim test (FST). The observed activity was compared with that of SJW extracts containing hyperforin and adhyperforin (in free form). Results indicate that hyperforin conjugates exhibit significant antidepressant acti vity as evidenced by the reduced immobility period in the FST in rats. Extracts of Hypericum perforatum Linn. (St.John's ministered (50 mg/kg/day) orally for three days in wort, SJW) have shown significant antidepressant 0 .3% CMC suspension. The experiment was per activity in both expenmenta. 1 1· 2 an d c l'mtca . l stu d'te s 3 . formed after 45 min of the final administration of the Earli er, hypericin, a napthodiantherene derivative pre drugs or the vehicle. sent in SJW, was thought to be the active constituent SJW Extracts- In a typical experiment, the dried responsible for the antidepressant activit/. However, overground parts of the H. peiforatum (SJW), col in later studies the earlier results could not be con lected from Northern India, were extracted continu firmed5. -
Hyperici Herba (Pharm
30 January 2018 EMA/HMPC/244315/2016 Committee on Herbal Medicinal Products (HMPC) Assessment report on Hypericum perforatum L., herba Draft Based on Article 10a of Directive 2001/83/EC as amended (well-established use) Based on Article 16d(1), Article 16f and Article 16h of Directive 2001/83/EC as amended (traditional use) Herbal substance(s) (binomial scientific Hypericum perforatum L., herba name of the plant, including plant part) Herbal preparation(s) Traditional use a) Dry extract (DER 4-7:1), extraction solvent ethanol 38% (m/m) = 45% V/V b) Liquid extract (DER 1:4-20), extraction solvent vegetable oil c) Liquid extract (DER 1:13), extraction solvent maize oil or other suitable vegetable oil d) Tincture (ratio herbal substance : extraction solvent 1:10), extraction solvent ethanol 45-50% (V/V) e) Liquid extract (DER 1:2-7), extraction solvent ethanol 50% (V/V) f) Expressed juice from the fresh herb (DER 1:0.5-0.9) g) Comminuted herbal substance h) Powdered herbal substance Well-established use a) Dry extract (DER 3-7:1), extraction solvent methanol (80% V/V) b) Dry extract (DER 3-6:1), extraction solvent ethanol (80% V/V) 30 Churchill Place ● Canary Wharf ● London E14 5EU ● United Kingdom Telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 5555 Send a question via our website www.ema.europa.eu/contact An agency of the European Union © European Medicines Agency, 2018. Reproduction is authorised provided the source is acknowledged. c) Dry extract (DER 2.5-8:1), extraction solvent ethanol (50-68% V/V) Pharmaceutical form(s) Comminuted herbal substance as herbal tea for oral use.